Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of endoglin polypeptides for modifying the regulatory activity of TGF-.beta.

Use of endoglin polypeptides for modifying the regulatory activity of TGF-.beta.

US Patent 5719120 · Granted Feb 17, 1998

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treating metastatic cancer and model systems for metastatic disease2024
Methods for treating brain metastasis2024
Treating metastatic cancer and model systems for metastatic disease2022
Modulating permeability of the blood cerebrospinal fluid barrier2022
Methods for treating brain metastasis2021
Methods for treating brain metastasis2019
Migrastatins and uses thereof2017
Migrastatins and uses thereof2016
Method of predicting and reducing risk of metastasis of breast cancer to lung2014
Method of predicting and reducing risk of metastasis of breast cancer to lung2012
Assay for anti-metastatic agents2010
Use of compounds that bind soluble endoglin and SFLT-1 for the treatment of preg2010